Library
All documents
The needs and expectations of a global industry - Mr. Carel du Marchie Sarvaas - HealthforAnimals
VICH 5 Session 2: Keynote Addresses
VICH/OIE training strategy - Dr. Steven Vaughn - U.S. FDA
VICH 5 Session 2: Keynote Addresses
Trends in research and development of new veterinary drug substances and products - Dr. Mark Micallef - Zenoaq, Japan
VICH 5 Session 4: Voice of Industries
Benchmarking the Livestock Business Environment - Mrs. Edna Kallon - World Bank, USA
VICH 5 Session 4: Voice of Industries
Statement of principle for VICH the "3R" approach & Alternatives to Animal Testing - Dr. Nicholas Jarrett - EU/VICH EU coordinator
VICH 5 Session 5: Contribution to animal welfare in tests for VMPs
Waiver of Target Animal Batch Safety Test - Dr. Marlies Halder - EU/Topic leader for TABST in the BQM EWG
VICH 5 Session 5: Contribution to animal welfare in tests for VMPs
The VICH pharmacovigilance guidelines - Dr. Margarita Brown - FDA
VICH 5 Session 6: VICH NOW
Bioequivalence - Dr. Marilyn Martinez - FDA
VICH 5 Session 6: VICH NOW
Development of a VICH guideline on stability studies to address climatic zones III and IV - Dr. Alice Sigobodhla - Department of Health, South Africa
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.